drugset / Trial / NCT00131391
A Study of MK0364 in Obese Patients (0364-014)
RandomizedParallel-groupDouble-blindTreatment
Summary
A worldwide study in obese patients to assess the efficacy, safety, and tolerability of an investigational drug.
Timeline
- Start
- 2005-07
- Primary completion
- 2008-02
- Completion
- 2008-12
Outcome
Outcome not reported
Stopped: “The overall profile does not support development for obesity”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | taranabant | Unknown | 2 mg | — |
| Subject | taranabant | Unknown | 4 mg | — |
| Subject | taranabant | Unknown | 6 mg | — |